IFF to sell Pharma Solutions business to Roquette for US$ 2.85 billion
Pharma Solutions operates 10 research and development and/or production sites globally
Pharma Solutions operates 10 research and development and/or production sites globally
The approved product has an estimated market size of US$ 44.5 million for the twelve months ending January 2024
Lonza plans to invest approximately CHF 500 million to upgrade the facility
The drug will be manufactured at the group’s formulation manufacturing facility at Ahmedabad SEZ II, India
Strategic multi-year research collaboration to identify novel targets with strong disease links and to accelerate clinical development
The drug will target specific genetic mutations prevalent in certain types of cancers
Chlorpromazine Hydrochloride Injection is used to treat certain mental/mood disorders
Company reaffirms commitment to reduce the global burden of HPV-related diseases, including certain cancers
Subscribe To Our Newsletter & Stay Updated